You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plasma Cell Dyscrasia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Web Application
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2022

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
Has Results
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

AL Amyloidosis, Plasma Cell Dyscrasia Trial in Nanjing

Enrolling by invitation
  • AL Amyloidosis
  • Plasma Cell Dyscrasia
    • Nanjing, Jiangsu, China
      National Clinical Research Center of Kidney Diseases, Jinling Ho
    Jan 26, 2021

    AL Amyloidosis Trial in Worldwide (CAEL-101, Placebo, cyclophosphamide, bortezomib, and dexamethasone (CyBorD) regimen)

    Recruiting
    • AL Amyloidosis
    • Phoenix, Arizona
    • +101 more
    Aug 4, 2022

    A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early

    Completed
    • Plasma Cell Dyscrasia
    • Monoclonal Gammopathy
      • Boston, Massachusetts
        Tufts Medical Center
      May 7, 2020

      Relapsed and/or Refractory Multiple Myeloma, Plasma Cell Leukemia in Relapse Trial in Shanghai (Biological)

      Recruiting
      • Relapsed and/or Refractory Multiple Myeloma
      • Plasma Cell Leukemia in Relapse
      • Biological
      • Shanghai, Shanghai, China
        Shanghai Tongji Hospital
      May 29, 2023

      Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)

      Recruiting
      • Multiple Myeloma
      • Plasma Cell Leukemia
      • CT0594CP
      • Suzhou, Jiangsu, China
        First Affiliated Hospital, Soochow University
      Apr 18, 2023

      Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)

      Not yet recruiting
      • Multiple Myeloma
      • Primary Plasma Cell Leukemia
      • Experimental: CAR-T cells Infusion
      • Shanghai, China
        Shanghai Changzheng Hospital
      Apr 20, 2023

      Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

      Recruiting
      • Plasma Cell Leukemia
      • anti-BCMA CAR-T
      • VRD-based regimen
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      Aug 4, 2023

      Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))

      Not yet recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Plasma Cell Leukemia
      • CAR-T (CAR-GPRC5D)
      • (no location specified)
      Feb 26, 2023

      Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

      Recruiting
      • Multiple Myeloma
      • Plasma Cell Leukemia
      • Human BCMA targeted CAR-NK cells injection
      • Shanghai, Shanghai, China
        Shanghai Changzheng Hospital
      Sep 13, 2023

      Myelodysplastic Disorders, Leukemia, Multiple Myeloma Trial in Houston (FLUDARABINE, CAMPATH 1H, FK50)

      Completed
      • Myelodysplastic Disorders
      • +4 more
      • Houston, Texas
      • +1 more
      Jan 15, 2020

      Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)

      Recruiting
      • Plasma Cell Leukemia
      • anti-BCMA CAR-T
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      May 13, 2023

      Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics

      Recruiting
      • Endometrial Cancer
      • low-depth whole-genome sequencing technology
      • Guangzhou, Guangdong, China
        The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
      Oct 9, 2023

      Thrombosis in Multiple Myeloma in an University Medical Center

      Recruiting
      • Multiple Myeloma
      • +2 more
      • Multiple myeloma
      • Groningen, Netherlands
        University Medical Center Groningen
      Sep 12, 2022

      Multiple Myeloma Trial in Wuhan (SENL103)

      Recruiting
      • Multiple Myeloma
      • SENL103
      • Wuhan, Hubei, China
        Tongji Hospital
      Sep 27, 2023

      COVID-19, Hematopoietic Stem Cell Transplantation Trial in Tianjin (COVID Convalescent Plasma)

      Recruiting
      • COVID-19
      • Hematopoietic Stem Cell Transplantation
      • COVID Convalescent Plasma
      • Tianjin, None Selected, China
        Institute of Hematology & Blood Diseases Hospital, Chinese Acade
      Jun 13, 2023

      Melanoma, NSCLC Trial (Evaluation of ctDNA using the F1T after 1 year of immunotherapy)

      Not yet recruiting
      • Melanoma
      • Non-small Cell Lung Cancer
      • Evaluation of ctDNA using the F1T after 1 year of immunotherapy
      • (no location specified)
      Nov 24, 2023

      Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics

      Recruiting
      • Ovarian Cancer
        • Guangzhou, Guangdong, China
          The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
        Jan 12, 2023

        Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics

        Active, not recruiting
        • Ovarian Cancer
          • Guangzhou, Guangdong, China
            The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
          Jan 12, 2023

          Healthy Trial (blood sampling)

          Not yet recruiting
          • Healthy
          • blood sampling
          • (no location specified)
          Apr 20, 2023

          PLAsma Genomic Testing in Advanced Non-Small Cell Lung Cancer:

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • ctDNA liquid biopsy - Roche Avenio Assay
          • (no location specified)
          Sep 14, 2022

          RRMM, Other Plasma Cell Diseases Trial (LM-305, Dexamethasone)

          Not yet recruiting
          • RRMM
          • Other Plasma Cell Diseases
          • (no location specified)
          Dec 1, 2022

          Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))

          Recruiting
          • Relapsed/Refractory Multiple Myeloma
          • Plasma Cell Leukemia
          • CAR-T (CAR-GPRC5D)
          • Wuhan, Hu Bei, China
            Tongji Hospital, Tongji Medical College, Huazhong University of
          May 17, 2022

          Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

          Not yet recruiting
          • Lymphoma, B-Cell
          • +6 more
          • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
          • Guayaquil, Guayas, Ecuador
            Instituto Oncológico Nacional Dr. Juan Tanca Marengo
          Apr 27, 2023